The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.
Eli Lilly on Wednesday said it had filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide, escalating its campaign against unauthorized sellers before the medici... [2310 chars]